{
    "2019-08-10": [
        [
            {
                "time": "",
                "original_text": "探营生物医药“次新股” 药企高管聚焦研发“生命线” 建言优化“再融资”路径",
                "features": {
                    "keywords": [
                        "生物医药",
                        "次新股",
                        "药企高管",
                        "研发",
                        "生命线",
                        "再融资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}